98%
921
2 minutes
20
Introduction: Enhancing productivity and nutrient content of soybean ( L.) is vital for sustainable agriculture. The utilization of beneficial bacterial and fungal strains has shown promising results in promoting plant growth and improving nutrient uptake. However, the effects of the individual and interactions of such microbes on soybean growth, yield, and nutrient profiling remain inadequately understood. Thus, there is a pressing need to comprehensively investigate the impact of tripartite microbial augmentation on soybean cultivation.
Methods: This field study aims to elucidate the synergistic mechanisms underlying the interactions between sp. MN54, , and and their collective influence on soybean growth parameters, yield and nutritional quality.
Results: compatibility tests revealed that consortium applications led to a maximum of 90% soybean germination. The field study demonstrated a significant increase in plant height (17.01%), nodules plant (17.35%), pods plant (12.11%), and grain yield (20.50%) due to triple inoculation over untreated control. The triple inoculation also significantly increased chlorophyll a, b, and leghemoglobin contents by 19.38, 21.01, and 14.28%, respectively, compared to control. Triple inoculation promoted crude fiber, protein, and oil content by 14.92, 8.78, and 10.52%, respectively, compared to the untreated control. The increase in nitrogen content by 7.33% in grains and 6.26% in stover and phosphorus by 11.31% in grains and 12.72% in stover was observed through triple application over untreated control.
Discussion: Our findings highlight the potential of microbial inoculants as biofertilizers in sustainable soybean production. The triple inoculation with sp. MN54, , and significantly improved soybean growth, yield, grain quality attributes, and nutrient uptake. This microbial consortium application could help to enhance agricultural productivity by boosting the nodulation in soybean and improving synergism between the microbial strains.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11925901 | PMC |
http://dx.doi.org/10.3389/fmicb.2024.1437489 | DOI Listing |
Lancet Reg Health West Pac
September 2025
State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, China.
Background: Cecolin9, a second-generation 9-valent HPV vaccine derived from the WHO-prequalified Cecolin, has received marketing authorisation in China in May 2025. The non-inferiority of type-specific immune responses between Cecolin9 and Gardasil9 has been previously established at month 7 in Chinese women aged 18-26 years (NCT04782895). This study aimed to compare the plateau antibody levels between the two vaccines three years post the first dose.
View Article and Find Full Text PDFPLoS One
September 2025
Agencia Costarricense de Investigaciones Biomédicas-Fundación INCIENSA (ACIB-FUNIN), San José, Costa Rica.
Previous SARS-CoV-2 research indicates that antibody levels and corresponding neutralization potential increase with additional exposures (comprising vaccination or infection), and that hybrid immunity resulting from combined vaccination and natural infection is more robust than either alone. However, it is unclear whether or how antibody levels increase or eventually plateau with repeated exposures and how SARS-CoV-2 exposure differs by sex or other demographic factors. Research regarding the association of antibody production with neutralization potential is also limited.
View Article and Find Full Text PDFBrain Behav
September 2025
Department of Transplant and Infection Immunology, Saarland University, Homburg, Germany.
Background: Immune induction under B-cell depletion is complex and far from being fully understood.
Methods: We investigated clinical and immunological responses after dual homologous mRNA vaccination with BNT162b2 and after booster vaccination or infection in 14 B-cell depleted patients with inflammatory central nervous system disease in comparison to 28 healthy controls. Spike-specific IgG were determined using ELISA and neutralizing activity by surrogate assay.
Vaccines (Basel)
July 2025
Department of Medicine, Gødstrup Hospital, 7400 Herning, Denmark.
Background: Kidney transplant recipients (KTRs) exhibit a significantly diminished immune response to Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) vaccines compared with the general population, primarily due to ongoing immunosuppressive therapy. This study evaluated the immunogenicity of a third SARS-CoV-2 mRNA vaccine dose in KTRs and assessed the association between antibody response and protection against SARS-CoV-2 breakthrough infection. Additionally, the clinical and immunological correlates of post-vaccination SARS-CoV-2 infection were examined.
View Article and Find Full Text PDFBiomedicines
July 2025
Department of Biology, University of Naples Federico II, 80126 Naples, Italy.
Since the COVID-19 pandemic, managing acute infections in symptomatic individuals, regardless of vaccination status, has been widely debated and extensively studied. Even more concerning, however, is the impact of COVID-19 on pregnant women-especially its effects on fetuses and newborns. Several studies have documented complications in both expectant mothers and their infants following infection.
View Article and Find Full Text PDF